Ernie Toth

Ernie Toth

Chief Financial Officer

Ernie Toth joined Aquestive as Interim CFO in December, 2020.  Prior to Aquestive he was CFO of EHE Health, a national preventive health, primary care, and telehealth network owned by Summit Partners and DW Healthcare Partners.  From January, 2016 to December 2016 he was Chief Financial Officer of ArisGlobal, an end to end drug development platform and from January, 2015 to December, 2015 Global Chief Financial Officer of Synowledge, a global life sciences solutions company providing drug safety, regulatory affairs and IT services to diverse pharmaceutical, biotechnology and medical devices companies. Owned by the Abbhi family, at both ArisGlobal and Synowledge he led Finance, HR, IT, Legal, and Commercial Operations during periods of high growth and the sale of Synowledge to Bioclinica.

Ernie was Chief Financial Officer from 2011 to 2013 of JHP Pharmaceuticals a PE owned (Morgan Stanley Private Investments) integrated specialty healthcare company that develops, manufactures and sells branded and generic aseptic injectable pharmaceuticals and provides contract manufacturing services for global pharmaceutical companies.  As CFO, Ernie provided financial and operational leadership through 9 new product launches, 17 ANDA filings, a BARDA award, clinical trials and the sale to Warburg Pincus in 2012.

From 2014 until its sale to a strategic buyer in 2017,  Ernie was a member of the Board of Directors of Eska, a leading Canadian beverage company owned by Morgan Stanley Private Investments.

Ernie prior experience includes senior financial leadership positions at Valeritas, Pharmaceutical Formulations, and World Power Technologies. He spent 15 years in various financial positions at MacAndrews & Forbes, the investment company owned by Ronald O. Perelman.

Ernie holds an MBA from Pace University, a BS in Accounting from Shippensburg University of Pennsylvania, and is a CPA in the State of New York.

Please complete this form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing info@aquestive.com or by calling 1-908-941-1900.

Please complete the form below and click SEND to receive a copy of “Overcoming Solubility and Permeability Challenges,” a case study detailing the achievements made by Aquestive’s formulation team to create the diazepam buccal film.

  • To subscribe to receive marketing updates about diazepam buccal film and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete the form to receive a demonstration kit for our PharmFilm® technology.

  • To subscribe to receive marketing updates about our PharmFilm® technology and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete this form:

  • To subscribe to receive marketing updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. If for any reason you no longer wish to receive information on Aquestive-sponsored clinical trials, you can contact us at any time by emailing clinicaltrials@aquestive.com.

Whether we are partnering to out license our PharmFilm® technology or in-licensing adjacent assets, Aquestive works hand-in-hand with our partners to address their toughest clinical and business challenges. To learn more, please complete the following form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete the form below and click submit to receive a copy of “The Art of LGS Book.”